Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05403086

Organisation Name: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Overal Status: Not yet recruiting

Start Date: October 1, 2022

Last Update: June 3, 2022

Lead Sponsor: Charles S. Grob, M.D.

Brief Summary: This multicenter, triple-blind, phase 2, randomized controlled trial will evaluate the efficacy and safety of psilocybin therapy compared to an active control in treating demoralization in adults near the end of life (≤2 years life expectancy).

Conditions:
  • Demoralization


Total execution time in seconds: 0.25134897232056